This inventor holds 5 USPTO granted patents and 10 published patent applications. Top assignee: Intellia Therapeutics, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovations by Jessica Lynn Seitzer
Introduction
Jessica Lynn Seitzer is an accomplished inventor based in Windham, NH (US). She has made significant contributions to the field of gene editing, particularly in relation to transthyretin (TTR) gene editing and the treatment of ATTR amyloidosis. With a total of two patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Jessica's latest patents focus on compositions and methods for TTR gene editing and treating ATTR amyloidosis. These patents provide innovative approaches for editing the TTR gene, including the introduction of double-stranded breaks. Additionally, her work offers methods for treating subjects suffering from amyloidosis associated with transthyretin (ATTR).
Career Highlights
Jessica is currently employed at Intellia Therapeutics, Inc., where she continues to develop her groundbreaking research. Her expertise in gene editing has positioned her as a key player in the biotechnology industry.
Collaborations
Jessica collaborates with talented individuals such as Arti Mahendra Prakash Kanjolia and Shobu Odate, contributing to a dynamic research environment that fosters innovation.
Conclusion
Jessica Lynn Seitzer's contributions to gene editing and her innovative patents are making a significant impact in the field of medicine. Her work exemplifies the potential of scientific research to address complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile